| Dr Aida Loudyi, MD | |
|
5550 Painted Mirage Rd Ste 110, Las Vegas, NV 89149-4581 | |
| (725) 204-1474 | |
| (725) 500-5049 |
| Full Name | Dr Aida Loudyi |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 22 Years |
| Location | 5550 Painted Mirage Rd Ste 110, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225152572 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 13307 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kingman Regional Medical Center | Kingman, AZ | Hospital |
| Entity Name | Las Vegas Rheumatology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316365141 PECOS PAC ID: 6406073030 Enrollment ID: O20140805002918 |
News Archive
A research report featured on the cover of the September 2009 print issue of The FASEB Journal describes how Australian scientists developed a new gene therapy vector that uses the same machinery that viruses use to transport their cargo into our cells. As a result of this achievement, therapeutic DNA can be transferred to a cell's nucleus far more efficiently than in the past, raising hopes for more effective treatment of genetic disorders and some types of cancers.
Human Genome Sciences, Inc.announced today that it has received a clinical development milestone payment from its partner, GlaxoSmithKline, related to the initiation of Phase 1 clinical trials of 677116 for the treatment of cardiovascular disease. 677116 is a small-molecule inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme associated with the formation of atherosclerotic plaques.
HIV-positive people in wealthy countries using highly active antiretroviral therapy now live an additional 13 years on average, but a large disparity in life expectancy remains between HIV-positive people on HAART and the general population, according to a study published Friday in the journal Lancet, Reuters reports.
A new program aimed at improving patient safety and quality care has been launched at McGill University Health Centre hospitals. The program, which is being conducted in collaboration with Vendorlink.ca, is the first of its kind in a large academic Quebec hospital.
› Verified 7 days ago
| Entity Name | American Arthritis Rheumatology Associates Kelly Nv Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659928315 PECOS PAC ID: 1658707245 Enrollment ID: O20200129002754 |
News Archive
A research report featured on the cover of the September 2009 print issue of The FASEB Journal describes how Australian scientists developed a new gene therapy vector that uses the same machinery that viruses use to transport their cargo into our cells. As a result of this achievement, therapeutic DNA can be transferred to a cell's nucleus far more efficiently than in the past, raising hopes for more effective treatment of genetic disorders and some types of cancers.
Human Genome Sciences, Inc.announced today that it has received a clinical development milestone payment from its partner, GlaxoSmithKline, related to the initiation of Phase 1 clinical trials of 677116 for the treatment of cardiovascular disease. 677116 is a small-molecule inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme associated with the formation of atherosclerotic plaques.
HIV-positive people in wealthy countries using highly active antiretroviral therapy now live an additional 13 years on average, but a large disparity in life expectancy remains between HIV-positive people on HAART and the general population, according to a study published Friday in the journal Lancet, Reuters reports.
A new program aimed at improving patient safety and quality care has been launched at McGill University Health Centre hospitals. The program, which is being conducted in collaboration with Vendorlink.ca, is the first of its kind in a large academic Quebec hospital.
› Verified 7 days ago
| Entity Name | Hummingbird Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164156790 PECOS PAC ID: 7012389646 Enrollment ID: O20230208001923 |
News Archive
A research report featured on the cover of the September 2009 print issue of The FASEB Journal describes how Australian scientists developed a new gene therapy vector that uses the same machinery that viruses use to transport their cargo into our cells. As a result of this achievement, therapeutic DNA can be transferred to a cell's nucleus far more efficiently than in the past, raising hopes for more effective treatment of genetic disorders and some types of cancers.
Human Genome Sciences, Inc.announced today that it has received a clinical development milestone payment from its partner, GlaxoSmithKline, related to the initiation of Phase 1 clinical trials of 677116 for the treatment of cardiovascular disease. 677116 is a small-molecule inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme associated with the formation of atherosclerotic plaques.
HIV-positive people in wealthy countries using highly active antiretroviral therapy now live an additional 13 years on average, but a large disparity in life expectancy remains between HIV-positive people on HAART and the general population, according to a study published Friday in the journal Lancet, Reuters reports.
A new program aimed at improving patient safety and quality care has been launched at McGill University Health Centre hospitals. The program, which is being conducted in collaboration with Vendorlink.ca, is the first of its kind in a large academic Quebec hospital.
› Verified 7 days ago
| Entity Name | Aida Loudyi Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316723646 PECOS PAC ID: 8224486683 Enrollment ID: O20231122002419 |
News Archive
A research report featured on the cover of the September 2009 print issue of The FASEB Journal describes how Australian scientists developed a new gene therapy vector that uses the same machinery that viruses use to transport their cargo into our cells. As a result of this achievement, therapeutic DNA can be transferred to a cell's nucleus far more efficiently than in the past, raising hopes for more effective treatment of genetic disorders and some types of cancers.
Human Genome Sciences, Inc.announced today that it has received a clinical development milestone payment from its partner, GlaxoSmithKline, related to the initiation of Phase 1 clinical trials of 677116 for the treatment of cardiovascular disease. 677116 is a small-molecule inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme associated with the formation of atherosclerotic plaques.
HIV-positive people in wealthy countries using highly active antiretroviral therapy now live an additional 13 years on average, but a large disparity in life expectancy remains between HIV-positive people on HAART and the general population, according to a study published Friday in the journal Lancet, Reuters reports.
A new program aimed at improving patient safety and quality care has been launched at McGill University Health Centre hospitals. The program, which is being conducted in collaboration with Vendorlink.ca, is the first of its kind in a large academic Quebec hospital.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aida Loudyi, MD 5550 Painted Mirage Rd Ste 110, Las Vegas, NV 89149-4581 Ph: (725) 204-1474 | Dr Aida Loudyi, MD 5550 Painted Mirage Rd Ste 110, Las Vegas, NV 89149-4581 Ph: (725) 204-1474 |
News Archive
A research report featured on the cover of the September 2009 print issue of The FASEB Journal describes how Australian scientists developed a new gene therapy vector that uses the same machinery that viruses use to transport their cargo into our cells. As a result of this achievement, therapeutic DNA can be transferred to a cell's nucleus far more efficiently than in the past, raising hopes for more effective treatment of genetic disorders and some types of cancers.
Human Genome Sciences, Inc.announced today that it has received a clinical development milestone payment from its partner, GlaxoSmithKline, related to the initiation of Phase 1 clinical trials of 677116 for the treatment of cardiovascular disease. 677116 is a small-molecule inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme associated with the formation of atherosclerotic plaques.
HIV-positive people in wealthy countries using highly active antiretroviral therapy now live an additional 13 years on average, but a large disparity in life expectancy remains between HIV-positive people on HAART and the general population, according to a study published Friday in the journal Lancet, Reuters reports.
A new program aimed at improving patient safety and quality care has been launched at McGill University Health Centre hospitals. The program, which is being conducted in collaboration with Vendorlink.ca, is the first of its kind in a large academic Quebec hospital.
› Verified 7 days ago
Dr. Arshi A. Quadeer, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-737-5043 | |
Cherie Lin, D.O. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109 Phone: 702-369-5582 Fax: 702-369-1533 | |
Michael M Lee, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-921-6823 Fax: 702-549-5240 | |
Henry Palangdao Igid, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144 Phone: 702-243-7200 Fax: 702-243-7235 | |
Ian Adrian Fanoga Frani, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 702-383-3875 | |
Sein Tun, DO Rheumatology Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4000 | |
Berge Jack Dadourian, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145 Phone: 702-906-1100 Fax: 702-906-1110 |